Terns Pharmaceuticals

$17.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+1.13%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TERN and other stocks, options, and ETFs commission-free!

About TERN

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.

CEO
Senthil Sundaram
Employees
30
Headquarters
Foster City, California
Founded
2017
Market Cap
452.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
154.41K
High Today
$18.52
Low Today
$17.05
Open Price
$17.17
Volume
240.86K
52 Week High
$28.36
52 Week Low
$14.83

TERN Earnings

-$3.65
-$2.43
-$1.22
-$0.00
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 17, After Hours

You May Also Like

FREQ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure